SE9503731L - Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning - Google Patents

Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Info

Publication number
SE9503731L
SE9503731L SE9503731A SE9503731A SE9503731L SE 9503731 L SE9503731 L SE 9503731L SE 9503731 A SE9503731 A SE 9503731A SE 9503731 A SE9503731 A SE 9503731A SE 9503731 L SE9503731 L SE 9503731L
Authority
SE
Sweden
Prior art keywords
solutions
preservatives
pct
injection
contexts
Prior art date
Application number
SE9503731A
Other languages
English (en)
Other versions
SE9503731D0 (sv
SE505274C2 (sv
Inventor
Sten Andersson
Haakan Eriksson
Kaare Larsson
Original Assignee
Sten Andersson
Haakan Eriksson
Larsson Kare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sten Andersson, Haakan Eriksson, Larsson Kare filed Critical Sten Andersson
Priority to SE9503731A priority Critical patent/SE505274C2/sv
Publication of SE9503731D0 publication Critical patent/SE9503731D0/sv
Priority to AT96935707T priority patent/ATE222802T1/de
Priority to JP9516525A priority patent/JPH11514920A/ja
Priority to DE69623354T priority patent/DE69623354T2/de
Priority to CA002235767A priority patent/CA2235767A1/en
Priority to AU73524/96A priority patent/AU693047B2/en
Priority to EP96935707A priority patent/EP0956155B1/en
Priority to PCT/SE1996/001306 priority patent/WO1997015391A1/en
Priority to US09/051,752 priority patent/US5936061A/en
Publication of SE9503731L publication Critical patent/SE9503731L/sv
Publication of SE505274C2 publication Critical patent/SE505274C2/sv

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/16—Alumino-silicates
    • B01J20/18—Synthetic zeolitic molecular sieves
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/64—In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
SE9503731A 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning SE505274C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning
US09/051,752 US5936061A (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
CA002235767A CA2235767A1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
JP9516525A JPH11514920A (ja) 1995-10-24 1996-10-15 ポリペプチド溶液から防腐剤を除去するための疎水性ゼオライトの使用、シリンジおよび方法
DE69623354T DE69623354T2 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
AT96935707T ATE222802T1 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
AU73524/96A AU693047B2 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
EP96935707A EP0956155B1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
PCT/SE1996/001306 WO1997015391A1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Publications (3)

Publication Number Publication Date
SE9503731D0 SE9503731D0 (sv) 1995-10-24
SE9503731L true SE9503731L (sv) 1997-04-25
SE505274C2 SE505274C2 (sv) 1997-07-28

Family

ID=20399935

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Country Status (9)

Country Link
US (1) US5936061A (sv)
EP (1) EP0956155B1 (sv)
JP (1) JPH11514920A (sv)
AT (1) ATE222802T1 (sv)
AU (1) AU693047B2 (sv)
CA (1) CA2235767A1 (sv)
DE (1) DE69623354T2 (sv)
SE (1) SE505274C2 (sv)
WO (1) WO1997015391A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802140D0 (sv) * 1998-06-16 1998-06-16 Ordio Ab Zeoliter för adsorption
SE9804029D0 (sv) * 1998-12-09 1998-12-09 Ordio Ab Adsorption av ftalater
US6589224B2 (en) * 2001-02-14 2003-07-08 Renal Tech International Llc Method of introducing fluids into a patient's body
US20050031708A1 (en) * 2003-08-06 2005-02-10 Portney Micah S. Composition comprising a zeolite compound for treatment of diseases
US20090111751A1 (en) * 2006-02-24 2009-04-30 Novo Nordisk Health Care Ag Method of Removing a Non-Metallic Protein Inhibitor From a Liquid Pharmaceutical Preparation
CA2574746A1 (en) * 2007-01-22 2008-07-22 Duoject Medical Systems Inc. Syringe having venting structure and method for mixing two substances in a syringe
WO2009027478A2 (en) * 2007-08-29 2009-03-05 Novo Nordisk Health Care Ag A method of removing preservatives from a liquid pharmaceutical preparation
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
EP3179975A4 (en) * 2014-08-13 2018-04-18 University of Florida Research Foundation, Inc. Preservative removal from eye drops
WO2016196516A1 (en) 2015-06-03 2016-12-08 William Kenneth Ward Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives
CN109069740B (zh) * 2016-04-22 2021-10-29 伊莱利利公司 用于减少胰岛素中的间甲酚浓度的具有包含聚合吸着剂的组件的输注组
EP3618890A1 (en) 2017-05-01 2020-03-11 Becton, Dickinson and Company Filter for reducing phenolic compounds from insulin and related infusion and injection devices
MX2019014615A (es) 2017-06-08 2020-02-07 Amgen Inc Dispositivo de administracion de farmacos accionado por par de torsion.
JP7517996B2 (ja) * 2018-04-27 2024-07-17 ベクトン・ディキンソン・アンド・カンパニー 送達デバイスおよび吸着剤
WO2019236653A1 (en) * 2018-06-06 2019-12-12 Entopsis Llc System and method for removing phenolic preservations from insulin formulations
CN115397374A (zh) 2019-12-19 2022-11-25 特清公司 从滴眼剂中去除防腐剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240986A (en) * 1979-02-23 1980-12-23 Uop Inc. Process for the separation of ortho-chloronitrobenzene
EP0021267B1 (en) * 1979-06-18 1982-06-16 PQ Corporation Agglomerated zeolite ion exchanger
SE8902919L (sv) * 1989-09-05 1991-03-05 Haakan Eriksson Anvaendning av zeoliter som adsorbenter av detergenter i biokemiska/biotekniska system och processer
SE9201976D0 (sv) * 1992-06-26 1992-06-26 Tektolit Ab Haakan Eriksson En metod foer att adsorbera proteiner och peptider till hydrofoba zeoliter
US5314855A (en) * 1992-11-09 1994-05-24 Akzo N.V. Adsorbent compositions and methods of manufacture
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant

Also Published As

Publication number Publication date
CA2235767A1 (en) 1997-05-01
DE69623354D1 (de) 2002-10-02
WO1997015391A1 (en) 1997-05-01
JPH11514920A (ja) 1999-12-21
EP0956155B1 (en) 2002-08-28
EP0956155A1 (en) 1999-11-17
DE69623354T2 (de) 2003-01-09
AU7352496A (en) 1997-05-15
US5936061A (en) 1999-08-10
ATE222802T1 (de) 2002-09-15
SE9503731D0 (sv) 1995-10-24
SE505274C2 (sv) 1997-07-28
AU693047B2 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
SE9503731L (sv) Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning
EP0301570A3 (en) Oligopeptides useful for treating aids
CA2115348A1 (en) Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes
BR9714354A (pt) Oxadiazóis, processos para sua preparação e seu emprego como medicamentos
CA2181150A1 (en) Biologically Active Peptides from Functional Domains of Bactericidal/Permeability-Increasing Protein and Uses Thereof
CA2158058A1 (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
AU3909497A (en) Anti-chlamydial methods and materials
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
AU1679795A (en) Anti-fungal methods and materials
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
ATE281761T1 (de) Hyaluronsäure enthaltende flüssigkeit zur lagerung von hornhaut
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
DK0722344T3 (da) Fremgangsmåde til virusinaktivering i nærvær af en polyether og et middel
SE9600120D0 (sv) Novel medical use
PT789764E (pt) Nova familia de inibidores de protease e outras substancias biologicas activas
DK0653939T3 (da) Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner
SE9503620D0 (sv) Användning av proteinet S-100b i läkemedel samt läkemedel innehållande proteinet S-100b
FR2767058B1 (fr) Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
ATE149568T1 (de) Neues thrombininhibitorisches protein aus raubwanzen
ATE245438T1 (de) Verwendung von oligomerem matrixprotein aus knorpel zur behandlung von rheumatoider arthritis
FI961505A (sv) Nya peptidföreningar, som är terapeutiskt aktiva i blodkoaguleringssystem, förfarande för deras framställning och farmaceutiska kompositioner, som innehåller dem
RU1819621C (ru) Колонка дл гемосорбции
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
DE59609353D1 (de) Mittel zur subkutanen Verabreichung von Protein C
SE9702993L (sv) Antimikrobiell komposition

Legal Events

Date Code Title Description
NUG Patent has lapsed